Association of Thrombectomy With Stroke Outcomes Among Patient Subgroups
Author(s) -
Maarten G. Lansberg,
Michael Mlynash,
Scott Hamilton,
Sharon D. Yeatts,
Sören Christensen,
Stephanie Kemp,
Philip W. Lavori,
Santiago OrtegaGutiérrez,
Joe Broderick,
Jeremy J. Heit,
Michael P. Marks,
Gregory W. Albers
Publication year - 2019
Publication title -
jama neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.298
H-Index - 231
eISSN - 2168-6157
pISSN - 2168-6149
DOI - 10.1001/jamaneurol.2018.4587
Subject(s) - medicine , modified rankin scale , randomized controlled trial , stroke (engine) , odds ratio , magnetic resonance imaging , middle cerebral artery , perfusion scanning , cardiology , physical therapy , radiology , perfusion , ischemia , ischemic stroke , mechanical engineering , engineering
The DEFUSE 3 randomized clinical trial previously demonstrated benefit of endovascular thrombectomy for acute ischemic stroke in the 6- to 16-hour time window. For treatment recommendations, it is important to know if the treatment benefit was universal.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom